As ablation of the Nlrc5 gene does not completely abolish MHC-I expression, especially in non-hematopoietic cells, it should be possible to test using NLRC5-deficient mice whether NLRC5 plays a crucial role in cancer immune surveillance and selection of immune escape variants. This evidence concerns the gene NLRC5 and cancer.